Small Molecule Targeted Cancer Therapy Market to Hit US$ 225.45 million by 2030 | Accelerating CAGR of 6.40%, Growth Plus Reports
19 janv. 2023 09h33 HE
|
Growth Plus Reports
Newark, New Castle, USA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global small molecule targeted cancer therapy market is expected to...
1ST Biotherapeutics, Inc., Announces FDA Clearance of IND Application for Phase 1/2 Study of FB849 to Treat Patients with Advanced Solid Tumors
13 déc. 2022 04h00 HE
|
AKAMPION
- Initiation of Phase 1/2 Clinical Trial Expected in Q1 2023 YONGIN, South Korea, December 13, 2022 -- 1ST Biotherapeutics, Inc., a clinical-stage biotechnology company focused on the development...
The Global Cancer Therapy Market to Witness Tremendous Growth at a CAGR of 9.12% During the Forecast Period (2019–2027) | DelveInsight
15 nov. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Global Cancer Therapy Market to Witness Tremendous Growth at a CAGR of 9.12% During the Forecast Period (2019–2027) | DelveInsight The global...
Scitech and the Plough Center Announce Manufacturing Agreement
20 oct. 2022 09h00 HE
|
SciTech Development
GROSSE POINTE FARMS, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug...
Peptide Therapeutics Market Worth USD 91.25 Billion with Grow at a CAGR of 8.8% from 2022 to 2031 | TMR Study
13 oct. 2022 13h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the global peptide therapeutics market size stood at around US$ 39.34 Bn. The...
NKGen Biotech to Present at the Baird 2022 Global Healthcare Conference
07 sept. 2022 14h00 HE
|
NKGen Biotech
SANTA ANA, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...
NKGen Biotech To Present SNK01 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2022
06 sept. 2022 14h37 HE
|
NKGen Biotech
SANTA ANA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
Novel Drug Delivery Systems in Cancer Therapy Market is Expected to Reach US$ 88.5 billion in 2032 - Future Market Insights, Inc.
08 juin 2022 09h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, June 08, 2022 (GLOBE NEWSWIRE) -- The novel drug delivery systems in the cancer therapy market are predicted to account for US$ 88.5 billion in 2032, up from US$ 14.8 billion in 2022,...
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
05 janv. 2022 08h00 HE
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
F-star Therapeutics to Host Virtual R&D Day on December 6, 2021
29 nov. 2021 08h00 HE
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...